Sanofi, Ten Percent Owner at Regeneron, holds 75.67M shares in Translate Bio (Ticker: ~TBIO), holds 3.16M shares in Icosavax (Ticker: ICVX), holds 520.13K shares in Inozyme Pharma (Ticker: INZY).
Sanofi latest transaction was an Uninformative Buy of $1.96B.
What was Sanofi's most profitable transaction?
Sanofi’s most profitable transaction was an Informative Buy of MYOK stock on October 5, 2016. The return on the trade was 145.60%.
What is Sanofi's role in Regeneron?
Sanofi's role in Regeneron is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.